Page last updated: 2024-08-25

perindoprilat and Benign Neoplasms

perindoprilat has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castellani, WJ; Heffelfinger, S; Molteni, A; Moulder, JE; Uhal, B	1

Reviews

1 review(s) available for perindoprilat and Benign Neoplasms

Article	Year
Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy. Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Cells, Cultured; Humans; Indoles; Neoplasms; Prospective Studies; Radiation-Protective Agents; Retrospective Studies; Tumor Cells, Cultured	2006

Article

Year

Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy.

Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:5

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Cells, Cultured; Humans; Indoles; Neoplasms; Prospective Studies; Radiation-Protective Agents; Retrospective Studies; Tumor Cells, Cultured

2006